Results 91 to 100 of about 1,092,726 (266)

Characterization of a Cohort of Patients with Chronic Thromboembolic Pulmonary Hypertension from Northeastern Colombia (REHINO Study)

Journal of Respiration, 2021
Chronic thromboembolic disease (CTEPH) is one of the causes for developing pulmonary hypertension (PH). PH is characterized by an increase in pulmonary vascular pressure and resistance, ultimately leading to chronic overload.
Javier Enrique Fajardo-Rivero, Melissa Mogollón, Diego Fernando García-Bohórquez, Andrés Villabona-Rueda, Tania Mendoza-Herrera, Alba Ramírez-Sarmiento, Fabio Bolívar-Grimaldos, Mauricio Orozco-Levi   +7 more
doaj   +1 more source

Factors affecting patient outcomes in pulmonary artery thromboendarterectomy under deep hypothermic circulatory arrest and cardiopulmonary bypass support----a single center's experience. [PDF]

BMC Cardiovasc Disord
Guan M, Yang X, Fu L, Zhao X, Hei F.
europepmc   +3 more sources

PH Professional Network: The Role of the Advanced Practice Nurse With Patients Undergoing Pulmonary Thromboendarterectomy and Balloon Pulmonary Angioplasty for CTEPH

Advances in Pulmonary Hypertension, 2022
Advanced practice nurses play an integral role in the management of chronic thromboembolic pulmonary hypertension patients undergoing pulmonary thromboendarterectomy and balloon pulmonary angioplasty.
Wendy Nelson, Mary Miller, Shannon A. Salveson   +2 more
semanticscholar   +1 more source

Implication to predict postoperative atrial fibrillation following pulmonary thromboendarterectomy

Journal of cardiac surgery, 2022
To the Editor, Liu and colleagues demonstrated that the development of postoperative atrial fibrillation (POAF) was not rare after pulmonary thromboendarterectomy (PTE), and the resting heart rate and age were their preoperative predictors.
Nobuhiro Nishida, T. Imamura
semanticscholar   +1 more source

Chronic Thromboembolic Pulmonary Hypertension [PDF]

, 2010
The pulmonary hypertension (PH) and right heart dysfunction that results from chronic thromboembolic involvement of the pulmonary vascular bed is potentially curable with surgical endarterectomy. Over the past several decades, growing clinical experience
A Keogh, A Ribeiro, AG Corsico, B Thompson, CJ Archibald, E Mayer, F Reichenberger, FG Vassallo, J Suntharalingam, K Jensen, K Moser, Lara M. Wittine, M Miniati, M Wolf, MM Hoeper, N Kim, N Nagaya, N Skoro-Sajer, P Bresser, P Darteville, PA Thistlethwaite, PA Thistlethwaite, PA Thistlethwaite, R Condliffe, R Hartz, RJ Hughes, S Cabrol, S Jamieson, S Krug, T Iwase, T Kramm, V Pengo, William R. Auger, WR Auger, X Jais   +34 more
core   +3 more sources

Craniofacial Involvement of Mucormycosis: A Single‐Center Experience of 57 Cases From Shiraz, Iran

Canadian Journal of Infectious Diseases and Medical Microbiology, Volume 2025, Issue 1, 2025.
Background: The incidence of mucormycosis surged significantly during the COVID‐19 pandemic, particularly among patients with diabetes mellitus (DM), a history of corticosteroid use, or immunosuppression. In Iran, the heightened prevalence of this opportunistic fungal infection underscored the critical importance of timely and comprehensive treatment ...
Darioush Naddaffard, Omid Yousefi, Amirmohammad Farrokhi, Maryam Adel, Mahtab Jalali, Mina Yousefi, Reza Jalli, Reza Taheri, Mohammad Sadegh Masoudi, Satabdi Datta Choudhury   +9 more
wiley   +1 more source

Isolated pulmonary valve endocarditis with rapid progression: a case report and literature review

Journal of Cardiothoracic Surgery, 2021
Background Isolated pulmonary valve endocarditis (IPE) is rare, accounting for 1.5–2% of all cases of infective endocarditis. Herein, we describe a case of isolated pulmonary valve endocarditis with rapid progression in a 28-year-old male.
Ming-Xuan Zhang, Wei-Min Zhang, Chan Yu, Bo-Wen Zhao, Ran Chen, Mei Pan, Bei Wang   +6 more
doaj   +1 more source

JAK Inhibitors for Treatment of VEXAS Syndrome: A Systematic Review of 186 Cases

Dermatology Research and Practice, Volume 2025, Issue 1, 2025.
Objectives: Vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic (VEXAS) syndrome is an autoinflammatory disease with a wide spectrum of manifestations and no standard treatment. Janus kinase inhibitors (JAK‐I) are small‐molecule drugs that affect many molecular pathways.
Saeed Bahramian, Patrick Fazeli, Arezou Rafati, Sardar Demokri, Huria Memari, Amirali Soheili, Farzad Esmaeili, Mohammad Pourmehdi Ardebili, Haniye Erfani, Seyed Mohammad Vahabi, Ioannis D. Bassukas   +10 more
wiley   +1 more source

Surgical Management of Chronic Pulmonary Embolism [PDF]

, 2017
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but life‐threatening complication of acute pulmonary embolism (PE). This entity is the consequence of a persistent obstruction of the pulmonary arteries and progressive vascular remodeling ...
Vallejo, Fabian Andres Giraldo
core   +1 more source

Same‐Day Discharge Following Outpatient Balloon Pulmonary Angioplasty: A Single‐Center Experience

Pulmonary Circulation, Volume 14, Issue 4, October 2024.
ABSTRACT Overnight inpatient monitoring is common following balloon pulmonary angioplasty (BPA) for chronic thromboembolic pulmonary hypertension (CTEPH). We describe our institutional experience in same‐day discharge (SDD) after BPA. Across 78 BPA sessions, there were only 2 (2.6%) admissions for hemoptysis with no reperfusion lung injury or deaths at
Amit Saha, Jeffrey P. Chidester, Hurst M. Hall, Trushil Shah, Kelly M. Chin, Sonja D. Bartolome, Thomas P. Koshy   +6 more
wiley   +1 more source